Tag
Dhiren Chandulal Shah
2 articles
Parmax Pharma New Promoters Acquire 30.80% Stake
Parmax Pharma intimates BSE of proposed promoter reclassification following an open offer and share purchase agreement.
Acquirers Dhiren Shah and Sunil Shah, along with 10 PACs, acquired 11,52,450 sha
Parmax Pharma Acquirers Seek Majority Control via SPA
Acquirers led by Dhiren C. Shah and Sunil C. Shah to acquire control of Parmax Pharma through share purchase agreement, preferential allotment, and open offer.
SPA executed at ₹35 per share for 43,210